Quantitative determination of the antitumor alkyl ether phospholipid edelfosine by reversed-phase liquid chromatography-electrospray mass spectrometry: application to cell uptake studies and characterization of drug delivery systems.
Edelfosine is a synthetic alkyl ether phospholipid that represents a promising class of antitumor agents. However, analytical methods to measure these type compounds are scarce. The lack of a reliable methodology to quantify edelfosine is a major problem in ongoing and scheduled preclinical and clinical trials with this drug. We evaluated the applicability of high-performance liquid chromatography-mass spectrometry to determine edelfosine in biological samples and polymeric delivery systems. Sample pre-treatment involved polymer precipitation or cell lysis with methanol. HPLC separation was performed on an Alltima RPC(18) narrow-bore column and edelfosine quantification was done by electrospray ionization mass spectrometry (ESI-MS) using positive ion mode and selected ion monitoring. Assays were linear in the tested range of 0.3-10 microg/ml. The limit of quantification was 0.3 ng/sample in both matrices, namely biological samples and polymeric delivery systems. The interassay precision ranging from 0.79 to 1.49%, with relative errors of -6.7 and 12.8%. Mean extraction recovery was 95.6%. HPLC-ESI-MS is a reliable system for edelfosine analysis and quantification in samples from different sources, combining advantages of full automation (rapidity, ease of use, no need of extensive extraction procedures) with high analytical performance and throughput.
Blanco-Príeto
María J
MJ
Department of Pharmacy and Pharmaceutical Technology, Facultad de Farmacia, University of Navarra, C/Irunlarrea 1, E-31080 Pamplona, Spain.
Campanero
Miguel A
MA
Mollinedo
Faustino
F
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics; D002138:Calibration; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D016503:Drug Delivery Systems; D018922:HL-60 Cells; D006801:Humans; D007202:Indicators and Reagents; D010742:Phospholipid Ethers / Q000008:administration & dosage / Q000032:analysis* / Q000493:pharmacokinetics; D011786:Quality Control; D015203:Reproducibility of Results; D021241:Spectrometry, Mass, Electrospray Ionization
D000970:Antineoplastic Agents; D007202:Indicators and Reagents; D010742:Phospholipid Ethers; C026659:edelfosine